Skip to main content
Top
Published in: Current Urology Reports 2/2011

01-04-2011

Antibiotic Prophylaxis in Pediatric Urology: An Update

Author: Saul P. Greenfield

Published in: Current Urology Reports | Issue 2/2011

Login to get access

Abstract

This article discusses the use of antibiotic prophylaxis in the treatment of three common conditions encountered by the pediatric urologist: 1) children with urinary infection and structurally and neurologically normal urinary tracts; 2) children with vesicoureteral reflux (VUR); and 3) children with prenatally diagnosed ureteropelvic and ureterovesical obstruction. The literature remains unclear and contradictory. Additional significant risk factors for recurrent infection are age, circumcision status in boys, and toileting function. The evidence for the use of prophylaxis is best in those with VUR, although not everyone with VUR must be on medication. In the absence of definitive evidence, the clinician must individualize the treatment of each patient and family.
Literature
1.
go back to reference Wan J, Kaplinsky R, Greenfield, SP: Toilet habits of children evaluated for urinary tract infection. J Urol 1995, 154:797–799.PubMedCrossRef Wan J, Kaplinsky R, Greenfield, SP: Toilet habits of children evaluated for urinary tract infection. J Urol 1995, 154:797–799.PubMedCrossRef
2.
go back to reference Farhat W, Bagli DJ, Capolicchio G, et al.: The dysfunctional voiding scoring system: quantitative standardization of dysfunctional voiding symptoms in children. J Urol 2000, 164:1011–1015.PubMedCrossRef Farhat W, Bagli DJ, Capolicchio G, et al.: The dysfunctional voiding scoring system: quantitative standardization of dysfunctional voiding symptoms in children. J Urol 2000, 164:1011–1015.PubMedCrossRef
3.
go back to reference Conway PH, Cnaan A, Zaoutis T, et al: Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials. JAMA 2007, 298:179–186.PubMedCrossRef Conway PH, Cnaan A, Zaoutis T, et al: Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials. JAMA 2007, 298:179–186.PubMedCrossRef
4.
go back to reference Craig JC, Simpson JM, Williams GJ, et al.: Antibiotic prophylaxis and recurrent urinary tract infection in children. NEJM 2009, 361:1748–1759.PubMedCrossRef Craig JC, Simpson JM, Williams GJ, et al.: Antibiotic prophylaxis and recurrent urinary tract infection in children. NEJM 2009, 361:1748–1759.PubMedCrossRef
5.
go back to reference • Williams G, Craig JC: Prevention of recurrent urinary tract infection in children. Curr Op Inf Dis 2009, 22:72–76. This was a large prospective study of children with and without reflux, showing a slight advantage to prophylaxis. CrossRef • Williams G, Craig JC: Prevention of recurrent urinary tract infection in children. Curr Op Inf Dis 2009, 22:72–76. This was a large prospective study of children with and without reflux, showing a slight advantage to prophylaxis. CrossRef
6.
go back to reference Mori R, Fitzgerald A, Williams C, et al.: Antibiotic prophylaxis for children at risk of developing urinary tract infection: a systemic review. Acta Paed 2009, 98:1781–1786.CrossRef Mori R, Fitzgerald A, Williams C, et al.: Antibiotic prophylaxis for children at risk of developing urinary tract infection: a systemic review. Acta Paed 2009, 98:1781–1786.CrossRef
7.
go back to reference Montini G, Rigon L, Zuchetta P, et al.: Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled noninferiority trial. Pediatrics 2007, 122:1064–1071.CrossRef Montini G, Rigon L, Zuchetta P, et al.: Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled noninferiority trial. Pediatrics 2007, 122:1064–1071.CrossRef
8.
go back to reference Williams G, Wei L, Lee A, et al.: Long term antibiotics for preventing recurrent urinary tract infection in children (review). Cochrane Collaboration in the Cochrane Library 2009, John Wiley & Sons, Ltd pp 1–28. Williams G, Wei L, Lee A, et al.: Long term antibiotics for preventing recurrent urinary tract infection in children (review). Cochrane Collaboration in the Cochrane Library 2009, John Wiley & Sons, Ltd pp 1–28.
9.
go back to reference Cascio S, Colhoun E, Puri P: Bacterial colonization of the prepuce in boys with vesicoureteral reflux who receive antibiotic prophylaxis. J Peds 2000, 139:160–162.CrossRef Cascio S, Colhoun E, Puri P: Bacterial colonization of the prepuce in boys with vesicoureteral reflux who receive antibiotic prophylaxis. J Peds 2000, 139:160–162.CrossRef
10.
go back to reference Fisch N, Ashkenazi S, Davidowitz M: Prophylactic antibiotics and evaluation scheme following febrile urinary tract infection in children: a nationwide Israeli survey. IMAJ 2009, 11:677–682.PubMed Fisch N, Ashkenazi S, Davidowitz M: Prophylactic antibiotics and evaluation scheme following febrile urinary tract infection in children: a nationwide Israeli survey. IMAJ 2009, 11:677–682.PubMed
11.
go back to reference Chevalier I, Benoit G, Gauthier M, et al.: Antibiotic prophylaxis for childhood urinary tract infection: a national survey. J Ped Child Health 2008, 44:572–578.CrossRef Chevalier I, Benoit G, Gauthier M, et al.: Antibiotic prophylaxis for childhood urinary tract infection: a national survey. J Ped Child Health 2008, 44:572–578.CrossRef
12.
go back to reference Cheng CH, Ming-Horng T, Yhu-Chering H, et al.: Antibiotic resistance patterns of community-acquired urinary tract infections in children with vesicoureteral reflux receiving prophylactic antibiotic therapy. Peds 2008, 122:1212–1217.CrossRef Cheng CH, Ming-Horng T, Yhu-Chering H, et al.: Antibiotic resistance patterns of community-acquired urinary tract infections in children with vesicoureteral reflux receiving prophylactic antibiotic therapy. Peds 2008, 122:1212–1217.CrossRef
13.
go back to reference Lee SJ, Shim YH, Cho SJ, et al.: Probiotics prophylaxis in children with persistent primary vesicoureteral reflux. Pediatr Nephrol 2007, 22:1315–1320.PubMedCrossRef Lee SJ, Shim YH, Cho SJ, et al.: Probiotics prophylaxis in children with persistent primary vesicoureteral reflux. Pediatr Nephrol 2007, 22:1315–1320.PubMedCrossRef
14.
go back to reference Greenfield SP, Ng M, Wan J: Experience with vesicoureteral reflux in children: clinical characteristics. J Urol 1997, 158:574–577.PubMedCrossRef Greenfield SP, Ng M, Wan J: Experience with vesicoureteral reflux in children: clinical characteristics. J Urol 1997, 158:574–577.PubMedCrossRef
15.
go back to reference Cooper CS, Chung BI, Kirsch AJ, et al.: The outcome of stopping prophylactic antibiotics in older children with vesicoureteral reflux. J Urol 2000, 163:269–273.PubMedCrossRef Cooper CS, Chung BI, Kirsch AJ, et al.: The outcome of stopping prophylactic antibiotics in older children with vesicoureteral reflux. J Urol 2000, 163:269–273.PubMedCrossRef
16.
go back to reference Garin EH, Olavarria F, Garcia NV, et al.: Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Peds 2006, 117:626–632.CrossRef Garin EH, Olavarria F, Garcia NV, et al.: Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Peds 2006, 117:626–632.CrossRef
17.
go back to reference Roussey-Kesler G, Gadjos V, Idres N, et al.: Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study. J Urol 2008, 179:674–679.PubMedCrossRef Roussey-Kesler G, Gadjos V, Idres N, et al.: Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study. J Urol 2008, 179:674–679.PubMedCrossRef
18.
go back to reference Brandstrom P, Esbjorner E, Herthelius M, et al.: The Swedish reflux trial in children: I. Study design and study population characteristics. J Urol 2010, 184:274–279.PubMedCrossRef Brandstrom P, Esbjorner E, Herthelius M, et al.: The Swedish reflux trial in children: I. Study design and study population characteristics. J Urol 2010, 184:274–279.PubMedCrossRef
19.
go back to reference •• Brandstrom P, Esbjorner E, Herthelius M, et al.: The Swedish reflux trial in children: III. Urinary tract infection pattern. J Urol 2010, 184:286–291. The authors studied a well-defined group of children with grade 3 or 4 reflux who had a significant decrease in recurrent infections on prophylaxis. PubMedCrossRef •• Brandstrom P, Esbjorner E, Herthelius M, et al.: The Swedish reflux trial in children: III. Urinary tract infection pattern. J Urol 2010, 184:286–291. The authors studied a well-defined group of children with grade 3 or 4 reflux who had a significant decrease in recurrent infections on prophylaxis. PubMedCrossRef
20.
go back to reference •• Brandstrom P, Neveus T, Sixt R, et al.: The Swedish reflux trial in children: IV. Renal Damage. J Urol 2010, 184:292–297. The authors studied a well-defined group of children with grade 3 or 4 reflux who had significant prevention of new renal scarring while on prophylaxis. PubMedCrossRef •• Brandstrom P, Neveus T, Sixt R, et al.: The Swedish reflux trial in children: IV. Renal Damage. J Urol 2010, 184:292–297. The authors studied a well-defined group of children with grade 3 or 4 reflux who had significant prevention of new renal scarring while on prophylaxis. PubMedCrossRef
21.
go back to reference Sillen U, Brandstrom P, Jodal U, et al.: The Swedish reflux trial in children: V. Bladder dysfunction. J Urol 2010, 184:298–304.PubMedCrossRef Sillen U, Brandstrom P, Jodal U, et al.: The Swedish reflux trial in children: V. Bladder dysfunction. J Urol 2010, 184:298–304.PubMedCrossRef
22.
go back to reference Al-Sayyad A, Pike J, Leonard MP: Can prophylactic antibiotics safely be discontinued in children with vesicoureteral reflux? J Urol 2005, 174:1587–1589.PubMedCrossRef Al-Sayyad A, Pike J, Leonard MP: Can prophylactic antibiotics safely be discontinued in children with vesicoureteral reflux? J Urol 2005, 174:1587–1589.PubMedCrossRef
23.
go back to reference Georgaki-Angelaki H, Kostaridou S, Daikos GL, et al.: Long-term follow-up of children with vesicoureteral reflux with and without antibiotic prophylaxis. Scand J Inf Dis 2005, 37:842–845.CrossRef Georgaki-Angelaki H, Kostaridou S, Daikos GL, et al.: Long-term follow-up of children with vesicoureteral reflux with and without antibiotic prophylaxis. Scand J Inf Dis 2005, 37:842–845.CrossRef
24.
go back to reference Kitchens DM, Herndon A, Joseph DB: Outcome after discontinuing prophylactic antibiotics in children with persistent vesicoureteral reflux. J Urol 2010, 184:1594–1597.PubMedCrossRef Kitchens DM, Herndon A, Joseph DB: Outcome after discontinuing prophylactic antibiotics in children with persistent vesicoureteral reflux. J Urol 2010, 184:1594–1597.PubMedCrossRef
25.
go back to reference •• Peters CA, Skoog SJ, Arant BS, et al.: Summary of the AUA guideline on management of primary vesicoureteral reflux in children. J Urol 2010, 184:1134–1144. This is the most comprehensive meta-analysis of the literature, with well-reasoned conclusions regarding therapy. PubMedCrossRef •• Peters CA, Skoog SJ, Arant BS, et al.: Summary of the AUA guideline on management of primary vesicoureteral reflux in children. J Urol 2010, 184:1134–1144. This is the most comprehensive meta-analysis of the literature, with well-reasoned conclusions regarding therapy. PubMedCrossRef
26.
go back to reference •• Keren R, Carpenter MA, Hoberman A, et al.: Rationale and design issues of the randomized intervention for children with vesicoureteral reflux (RIVUR) study. Peds 2008, 5(Suppl):5240–5250. This article provides a comprehensive discussion of the RIVUR trial and its aims. •• Keren R, Carpenter MA, Hoberman A, et al.: Rationale and design issues of the randomized intervention for children with vesicoureteral reflux (RIVUR) study. Peds 2008, 5(Suppl):5240–5250. This article provides a comprehensive discussion of the RIVUR trial and its aims.
27.
go back to reference • Greenfield SP, Chesney RW, Carpenter M, et al.: Vesicoureteral reflux: the RIVUR study and the way forward. J Urol 2008, 179:405–407. This article provides a succinct analysis of the shortcomings of the current literature and a brief description of the RIVUR trial. PubMedCrossRef • Greenfield SP, Chesney RW, Carpenter M, et al.: Vesicoureteral reflux: the RIVUR study and the way forward. J Urol 2008, 179:405–407. This article provides a succinct analysis of the shortcomings of the current literature and a brief description of the RIVUR trial. PubMedCrossRef
28.
go back to reference Copp HL, Nelson CP, Shortliffe LD, et al.: Compliance with antibiotic prophylaxis in children with vesicoureteral reflux: results from a national pharmacy claims data base. J Urol 2010, 183:1994–2000.PubMedCrossRef Copp HL, Nelson CP, Shortliffe LD, et al.: Compliance with antibiotic prophylaxis in children with vesicoureteral reflux: results from a national pharmacy claims data base. J Urol 2010, 183:1994–2000.PubMedCrossRef
29.
go back to reference Wan J, Greenfield SP, Talley M, et al.: An analysis of social and economic factors associated with followup of patients with vesicoureteral reflux. J Urol 1996, 156:668–672.PubMedCrossRef Wan J, Greenfield SP, Talley M, et al.: An analysis of social and economic factors associated with followup of patients with vesicoureteral reflux. J Urol 1996, 156:668–672.PubMedCrossRef
30.
go back to reference Ogan K, Pohl H, Carlson D, et al.: Parental preferences in the management of vesicoureteral reflux. J Urol 2001, 240–243. Ogan K, Pohl H, Carlson D, et al.: Parental preferences in the management of vesicoureteral reflux. J Urol 2001, 240–243.
31.
32.
go back to reference Lee JH, Choi HS, Kim JK, et al.: Nonrefluxing neonatal hydronephrosis and the risk of urinary tract infection. J Urol 2008, 179:1524–1528.PubMedCrossRef Lee JH, Choi HS, Kim JK, et al.: Nonrefluxing neonatal hydronephrosis and the risk of urinary tract infection. J Urol 2008, 179:1524–1528.PubMedCrossRef
33.
go back to reference • Roth CC, Hubanks JM, Bright BC, et al.: Occurence of urinary tract infection in children with significant upper urinary tract obstruction. Urology 2009, 73:74–78. The authors studied a well-defined group of infants with prenatally diagnosed UPJO and UVJO who were followed off prophylaxis. PubMedCrossRef • Roth CC, Hubanks JM, Bright BC, et al.: Occurence of urinary tract infection in children with significant upper urinary tract obstruction. Urology 2009, 73:74–78. The authors studied a well-defined group of infants with prenatally diagnosed UPJO and UVJO who were followed off prophylaxis. PubMedCrossRef
34.
go back to reference Greenfield SP, Deshmukh S, Williot P: Prenatally detected primary ureterovesical junction obstruction: are prophylactic antibiotics necessary? Presented at the Urology Section, American Academy of Pediatrics, Washington, DC October 2009. Greenfield SP, Deshmukh S, Williot P: Prenatally detected primary ureterovesical junction obstruction: are prophylactic antibiotics necessary? Presented at the Urology Section, American Academy of Pediatrics, Washington, DC October 2009.
Metadata
Title
Antibiotic Prophylaxis in Pediatric Urology: An Update
Author
Saul P. Greenfield
Publication date
01-04-2011
Publisher
Current Science Inc.
Published in
Current Urology Reports / Issue 2/2011
Print ISSN: 1527-2737
Electronic ISSN: 1534-6285
DOI
https://doi.org/10.1007/s11934-010-0164-y

Other articles of this Issue 2/2011

Current Urology Reports 2/2011 Go to the issue